The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of BRAF mutant metastatic melanoma (MM) patients (pts) after cessation of targeted therapy (TT) with BRAF or BRAF/MEK inhibitor(i).
 
Natalie Jackson
No Relationships to Disclose
 
Theresa Rodgers
No Relationships to Disclose
 
Ida John
No Relationships to Disclose
 
Denai R. Milton
No Relationships to Disclose
 
Lauren Elaine Haydu
No Relationships to Disclose
 
Rodabe Navroze Amaria
Consulting or Advisory Role - Iovance Biotherapeutics; Nektar; Novartis
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); iovance Biotherapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Adi Diab
Honoraria - Array BioPharma
Consulting or Advisory Role - Celgene; CureVac; Idera; Nektar
Research Funding - Apexigen; Celgene (Inst); Idera (Inst); Merck; Nektar (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Nektar
 
Jennifer Leigh McQuade
Honoraria - Merck
Consulting or Advisory Role - Bristol Myer Squibb; Roche Pharma AG
Travel, Accommodations, Expenses - Merck
 
Sapna Pradyuman Patel
Honoraria - Merck
Consulting or Advisory Role - Cardinal Health; TriSalus Life Sciences
Research Funding - Bristol-Myers Squibb (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); InxMed (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Clinica Santa Maria; Merck
Other Relationship - Immunocore
 
Hussein Abdul-Hassan Tawbi
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Eisai; Genentech/Roche; Iovance Biotherapeutics; Merck; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst)
 
Michael K.K. Wong
Consulting or Advisory Role - Adagene; Bristol-Myers Squibb; Castle Biosciences; EMD Serono; Merck; Pfizer; Regeneron
Research Funding - Exicure; Kartos Therapeutics; Merck
 
Michael A. Davies
Consulting or Advisory Role - Apexigen; Array BioPharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; NanoString Technologies; Novartis; Sanofi; Syndax; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Isabella Claudia Glitza
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Novartis
Speakers' Bureau - Array BioPharma
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Lilly